MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- DISHMAN PHARMA - ADCOCK INGRAM (S. Africa)
DISHMAN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results
DISHMAN PHARMA Change
Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More
ADCOCK INGRAM (S. Africa)
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
Financials
 DISHMAN PHARMA  ADCOCK INGRAM |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| DISHMAN PHARMA Mar-16 |
ADCOCK INGRAM Jun-14 |
DISHMAN PHARMA/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 374 | 344 | - | |
| Low | Rs | 129 | 248 | - | |
| Sales per share (Unadj.) | Rs | 197.8 | 102.4 | - | |
| Earnings per share (Unadj.) | Rs | 21.2 | -25.8 | - | |
| Cash flow per share (Unadj.) | Rs | 34.7 | -21.4 | - | |
| Dividends per share (Unadj.) | Rs | 2.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.8 | 0 | - | |
| Book value per share (Unadj.) | Rs | 179.9 | 80.4 | - | |
| Shares outstanding (eoy) | m | 80.69 | 168.78 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 1.3 | 2.9 | 44.0% | |
| Avg P/E ratio | x | 11.9 | -11.5 | -103.3% | |
| P/CF ratio (eoy) | x | 7.2 | -13.9 | -52.3% | |
| Price / Book Value ratio | x | 1.4 | 3.7 | 37.9% | |
| Dividend payout | % | 9.4 | 0 | - | |
| Avg Mkt Cap | Rs m | 20,306 | 50,026 | 40.6% | |
| No. of employees | `000 | 0.8 | 4.3 | 19.3% | |
| Total wages/salary | Rs m | 5,355 | 3,140 | 170.6% | |
| Avg. sales/employee | Rs Th | 19,252.7 | 4,027.5 | 478.0% | |
| Avg. wages/employee | Rs Th | 6,459.5 | 731.4 | 883.2% | |
| Avg. net profit/employee | Rs Th | 2,064.1 | -1,014.8 | -203.4% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 15,961 | 17,290 | 92.3% | |
| Other income | Rs m | 265 | 121 | 219.2% | |
| Total revenues | Rs m | 16,226 | 17,411 | 93.2% | |
| Gross profit | Rs m | 4,103 | -2,996 | -136.9% | |
| Depreciation | Rs m | 1,091 | 746 | 146.1% | |
| Interest | Rs m | 944 | 468 | 201.6% | |
| Profit before tax | Rs m | 2,334 | -4,090 | -57.1% | |
| Minority Interest | Rs m | 0 | -11 | 0.0% | |
| Prior Period Items | Rs m | 1 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 624 | 256 | 244.0% | |
| Profit after tax | Rs m | 1,711 | -4,357 | -39.3% | |
| Gross profit margin | % | 25.7 | -17.3 | -148.4% | |
| Effective tax rate | % | 26.7 | -6.2 | -427.7% | |
| Net profit margin | % | 10.7 | -25.2 | -42.5% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 11,018 | 12,664 | 87.0% | |
| Current liabilities | Rs m | 9,517 | 7,125 | 133.6% | |
| Net working cap to sales | % | 9.4 | 32.0 | 29.4% | |
| Current ratio | x | 1.2 | 1.8 | 65.1% | |
| Inventory Days | Days | 110 | 111 | 99.6% | |
| Debtors Days | Days | 35 | 124 | 28.1% | |
| Net fixed assets | Rs m | 16,304 | 7,382 | 220.9% | |
| Share capital | Rs m | 161 | 80 | 201.1% | |
| Net worth | Rs m | 14,516 | 13,571 | 107.0% | |
| Long term debt | Rs m | 4,189 | 4,769 | 87.8% | |
| Total assets | Rs m | 29,805 | 25,636 | 116.3% | |
| Interest coverage | x | 3.5 | -7.7 | -44.9% | |
| Debt to equity ratio | x | 0.3 | 0.4 | 82.1% | |
| Sales to assets ratio | x | 0.5 | 0.7 | 79.4% | |
| Return on assets | % | 8.9 | -15.2 | -58.7% | |
| Return on equity | % | 11.8 | -32.1 | -36.7% | |
| Return on capital | % | 17.5 | -19.8 | -88.5% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 2,786 | 1,476 | 188.8% | |
| From Investments | Rs m | -1,529 | -453 | 337.4% | |
| From Financial Activity | Rs m | -941 | 4,328 | -21.7% | |
| Net Cashflow | Rs m | 316 | 5,351 | 5.9% | |
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.75 Rs / ZAR
Compare DISHMAN PHARMA With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare DISHMAN PHARMA With: ABBOTT INDIA FDC AUROBINDO PHARMA NEULAND LABS SHASUN PHARMA
Today's Market
Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)
Indian share markets witnessed huge selling during closing hours today and ended their day lower.
Related Views On News
Most Popular
It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)
Feb 23, 2021An Indian company founded three decades ago in a garage caught my attention...
How Much Money For Day Trading? (Fast Profits Daily)
Feb 22, 2021In this video, I'll show you how to allocate your capital as a day trader.
More
